Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Pain, Back: full-pipeline trial registry

5 of 8 indexed Pain, Back trials are currently recruiting.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 5 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Pain, Back: 8 US clinical trials tracked, 5 recruiting.

Pain, Back is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Iowa, running 1 of these trials.

Enrollment posture brief

Registry condition pain-back

OPEN 5 | RECR 63% | LATE 2 | EARLY 2 | RANK #2176 | SPON 1

Nearest open-share peer: Adolescent (63% recruiting · 16 trials)

Activity, Motor75%Pain, Back (this)63%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near Pain, Back

Pain, Back lists 5 open slots (63% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pain, Back on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pain, Back is recruiting above its size-band peers.

    5 of 8 indexed trials (62.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Pain, Back trials is spread across many organizations.

    University of Iowa accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Pain, Back enrolment sits around 109 participants.

    Median target enrolment is 109 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.

  4. Pain, Back research is mostly interventional.

    8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 31Phase 41

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Pain, Back records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Unactivated Lavender Elequil aromatabs® (#372) Other
1 trials
Activated Lavender Elequil aromatabs® (#372) Other
1 trials
Primary Spine Provider Model Other
1 trials
PremierMaxCB®-Platinum (CFL001); Biological
1 trials
Research electrode Device
1 trials
Numerical Rating Score (NRS) Other
1 trials
Generalized Anxiety Disorder 7-item (GAD-7) scale Other
1 trials
3D CAM Delirium Severity Scoring Other
1 trials

US sites by state

Facility locations filed on Pain, Back trials. A trial with sites in several states counts in each.

New York 2 trials
Iowa 2 trials
Oregon 1 trials
New Hampshire 1 trials
North Carolina 1 trials
Massachusetts 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pain, Back page

8 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pain, Back condition card totals 8 registered trials; most-linked intervention Unactivated Lavender Elequil aromatabs® (#372); top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.